Objective: To characterise the evolution of myocardial perfusion during the first 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging (CMR) and determine its significance.
Design: Prospective cohort design.
Setting: Single-centre study in a teaching hospital in Spain.
Patients: 40 patients with a first ST-elevation myocardial infarction, single-vessel disease and thrombolysis in myocardial infarction (TIMI) grade 3 flow (stent in 33 patients) underwent rest and low-dose dobutamine CMR 7 (SD 1) and 184 (SD 11) days after infarction. Microvascular perfusion was assessed at rest by visual assessment and quantitative analysis of first-pass perfusion CMR. Of the 640 segments, 290 segments subtended by the infarct-related artery (IRA) were focused on.
Results: Both 1 week and 6 months after infarction, segments with normal perfusion showed more wall thickening, contractile reserve and wall thickness, and less transmural necrosis, p <0.05 in all cases. Of 76 hypoperfused segments at the first week, 47 (62%) normalised perfusion at the sixth month. However, 42 segments (14% of the whole group) showed chronic abnormal perfusion; these segments showed worse CMR indices in the late phase (p<0.05 in all cases).
Conclusions: In patients with an open IRA, more than half of the segments with abnormal perfusion at the first week are normally perfused after six months. First-pass perfusion CMR shows that in a small percentage of segments, abnormal perfusion may become a chronic phenomenon—these areas have a more severe deterioration of systolic function, wall thickness, contractile reserve and the transmural extent of necrosis.
- CMR, cardiovascular magnetic resonance imaging
- IRA, infarct-related artery
- TIMI, thrombolysis in myocardial infarction
- True FISP, true fast imaging in steady-state precession
Statistics from Altmetric.com
Published Online First 27 June 2006
Funding: This study was supported by the Generalitat Valenciana (GRUPO0442) and by a grant from Guidant.
Competing interests: None.
Ethical approval: The local ethics committee approved the research protocol. Informed consent was obtained from all patients.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.